gold has been researched along with abiraterone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fusaro, M; Kubiszewski, M; Leś, A; Menaszek, E; Sidoryk, K; Stolarczyk, EU; Stolarczyk, K; Strzempek, W; Łaszcz, M | 1 |
| Baker, A; Khalid, M; Khan, MS; Uddin, I | 1 |
| Al-Rejaie, SS; Baker, A; Elgorban, AM; Mohany, M; Sajid Khan, M; Syed, A | 1 |
3 other study(ies) available for gold and abiraterone
| Article | Year |
|---|---|
The ligand exchange of citrates to thioabiraterone on gold nanoparticles for prostate cancer therapy.
Topics: Androstenes; Cell Line; Cell Survival; Citrates; Epithelial Cells; Gold; Humans; Ligands; Liver; Male; Metal Nanoparticles; Prostate; Prostatic Neoplasms; Sulfhydryl Compounds | 2020 |
Targeted non AR mediated smart delivery of abiraterone to the prostate cancer.
Topics: Androstenes; Apoptosis; Cell Line, Tumor; Gold; Humans; Male; Metal Nanoparticles; Prostatic Neoplasms; Survivin | 2022 |
Survivin-targeted nanomedicine for increased potency of abiraterone and enzalutamide against prostate cancer.
Topics: Gold; Humans; Male; Metal Nanoparticles; Nanomedicine; Prostatic Neoplasms, Castration-Resistant; Survivin | 2023 |